340B Report Publisher and CEO Slafsky: Three 340B Observations for 2023

U.S. Capitol with U.S flag
Expect the 340B program to be get signficant attention at the federal and state level this year, 340B Report Publisher and CEO Ted Slafsky says.

In his inaugural column for Verity Solutions, 340B Report Publisher and CEO Ted Slafsky offers insights “on what to expect in Washington, D.C., and the states in 2023 when it comes to the 340B program.”

Slafsky in the column makes

Read More »

Breaking News

Third Circuit Court Rules for Drugmakers in 340B Contract Pharmacy Cases

Interior of Third Circuit Court courtroom
A federal appeals court ruled today that the 340B statute does not compel drug manufacturers to deliver 340B-purchased drugs "wherever and to whomever a buyer demands."

A federal appeals court in Philadelphia ruled 3-0 this morning that “Congress never said that drug makers must deliver discounted Section 340B drugs to an unlimited number of contract pharmacies.”

“By trying to enforce that supposed requirement, the government overstepped

Read More »

New York Times 340B Hospital Exposé Leads to a Vote Later Today in a Virginia House Subcommittee

Kathy Tran headshot
Virginia Del. Kathy Tran (D) says her bill to to require more accountability from 340B hospitals was prompted by The New York Times' investigation of alleged 340B program misuse detrimental to a Richmond hospital in a predominantly Black neighborhood.

A Virginia House subcommittee is voting later today on a Democrat’s bill to require more accountability from 340B hospitals—a direct consequence of The New York Times’ exposé about alleged 340B program misuse involving a Richmond, Va., hospital.

The scheduled vote

Read More »

Missouri Lawmakers Try Again to Stop Drug Companies’ 340B Contract Pharmacy Restrictions

Missouri State Capitol building
Missouri lawmakers have reintroduced legislation to prohibit drug manufactures from denying 340B covered entities access to manufacturers’ products if the covered entity uses contract pharmacies.

Missouri lawmakers have reintroduced legislation to prohibit drug manufactures from denying 340B covered entities access to manufacturers’ products if the covered entity uses contract pharmacies. The language is modeled on the first-of-its kind law passed in Arkansas in 2021.

Missouri

Read More »

Staffing Success for a 340B Pharmacy

Sandie Shafer, Senior Talent Advisor, Pharmacy Operations, Maxor National Pharmacy Services featured image
Sandie Shafer, Senior Talent Advisor, Pharmacy Operations, Maxor National Pharmacy Services

SPONSORED CONTENT

The healthcare industry is grappling with a severe staffing shortage, and pharmacies are no exception. More than three-quarters of community pharmacists are struggling to fill open positions, and nearly 90% say finding pharmacy technicians is their top staffing problem, according to

Read More »

New York State Medicaid Drug Benefit Transfer, on Ice for Two Years, Is Back

Mark Malahosky pictured with March for 340B placard
“It’s not hyperbole to say if this is put into place, we’re going to have to cut services and cut staffing," Mark Malahosky of Trillium Health says of New York State's plan to shift Medicaid managed care prescription drug benefits into Medicaid fee for service.

With a two-year implementation delay nearly over, New York State is poised to fold its Medicaid managed care prescription drug benefits into its Medicaid fee for service system on April 1. State 340B health care providers that serve high volumes

Read More »

Guthrie and Griffith, as Expected, Will Helm House E&C Subcommittees Involved in 340B

U.S. Rep. Brett Guthrie (R-KY) and Rep. Morgan Griffith (R-VA) headshots
U.S. Rep. Brett Guthrie (left) (R-Ky.) will chair the Energy & Commerce Subcommittee on Health and Rep. Morgan Griffith (R-Va.) the Subcommittee on Oversight and Investigations.

U.S. House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) yesterday as expected announced that Rep. Brett Guthrie (R-Ky.) will chair the Subcommittee on Health and Rep. Morgan Griffith (R-Va.) the Subcommittee on Oversight and Investigations.

Guthrie said

Read More »

340B INDUSTRY LEADER SPOTLIGHT

ShaiAnn Howard, Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy

ShaiAnn Howard, 340B Director, Alliance Rx Walgreens Pharmacy
ShaiAnn Howard

Q: Where did you grow up?

I grew up in Racine, WI. I have lived in Wisconsin my entire life.

Q: Where did you go to college?

I attended Marquette University in Milwaukee, WI.

Q: What are your favorites?

Food: Tacos

Movie: All of the Harry Potter films

Musicians: Lady Gaga, Elvis Presley and Pink

Destination:

Read More »

House GOP Bill Would Stop Additional Hospitals and Child Sites from 340B Enrollment and Make it Harder for Current Hospitals to Remain Eligible

U.S. Rep. Matt Rosendale (R-MT)
U.S. Rep. Matt Rosendale (R-Mont.) has reintroduced a bill to put a moratorium on 340B hospital growth, impose 340B reporting requirements on hospitals, and make it harder for private nonprofit hospitals to stay in 340B.

A new U.S. House bill would put a moratorium on 340B hospital growth and impose a host of reporting requirements on 340B hospitals. It would also make it much harder for private nonprofit hospitals to remain in the 340B program.

Read More »

U.S. House Leaders Agree on Committee Ratios: Energy & Commerce Gets to Work 

Screenshot of Energy and Commerce welcome splash screen
The composition of the House Energy & Commerce Committee in this Congress is clear now that party leaders have agreed on committee sizes and ratios.

U.S. House Speaker Kevin McCarthy (R-Calif.) and Minority Leader Hakeem Jeffries (D-N.Y.) have reached an agreement on the balance of power in committees during this Congress and are expected to formally assign members to committees as soon as this week.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live